Feasibility of Integrating Thermotherapy for Treatment of Cutaneous Leishmaniasis in Primary Health Care Setup
Recruiting
N/A
Interventional Study
Cutaneous Leishmaniasis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 12 – 60
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 103 (estimated)
- Sponsor
- Armauer Hansen Research Institute, Ethiopia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study will look at how feasible it is to use thermotherapy (TT) as a treatment for skin(cutaneous) leishmaniasis (CL) in health centers in the Sodo and South Sodo districts, Ethiopia. The main questions the investigators want to answer are:
* Is it practical, acceptable, and suitable to use thermotherapy for treating skin leishmaniasis in these health centers?
* How effective is thermotherap…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Males and females aged ≥12 and ≤60 years old.
* Patient has a lesion that satisfies the following criteria:
* Lesion size \< or = 4 cm (longest diameter).
* Not located adjacent to ear, nose, eyes, lips, or close to mucosal membranes.
* Patient with \< or = 4 CL lesions…
Contacts